Skip to main content
SpringerLink
Log in

Insulin Resistance, and Hypertension

  • Chapter
Contemporary Concepts in Cardiology

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 217))

  • 93 Accesses

Abstract

The clinical states of non-insulin dependent diabetes mellitus (NIDDM), essential hypertension, and cardiovascular disease are major causes of morbidity and mortality in the United States. The prevalence of NIDDM in the U.S. currently approaches 5 to 7 percent.1 In 1992 this resulted in a cost to the health care system of approximately $45 billion.2 On a similar scale, cardiovascular disease contributes to approximately 900,000 deaths per year in the United States, nearly 40 percent of deaths due to all causes.3 Furthermore, essential hypertension is perhaps the most prevalent cardiovascular disease affecting an estimated 50 million Americans.3

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yki-Jarvinen H: Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 1994;343: 91.

    Article  PubMed  CAS  Google Scholar 

  2. Keen H: Insulin resistance and the prevention of diabetes mellitus. N Engl J Med 1994;331: 1226.

    Article  PubMed  CAS  Google Scholar 

  3. U.S.National Center for Health Statistics. Vital and Health Statistics 1992;10

    Google Scholar 

  4. Flier JS: Lilly lecture: Syndromes of insulin resistance. From patient to gene and back again. Diabetes 1992;41: 1207.

    Article  PubMed  CAS  Google Scholar 

  5. Kahn CR: Causes of insulin resistance. Nature 1995;373: 384.

    Article  PubMed  CAS  Google Scholar 

  6. Moller DE: Insulin Resistance. Chichester, England, John Wiley & Sons, 1993, p 1.

    Google Scholar 

  7. Shulman GI, Rothman DL, Jue T: Quantitation of muscle glycogen synthesis in normal subjects and in subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. The New England Journal of Medicine 1990;322: 223.

    Article  PubMed  CAS  Google Scholar 

  8. DeFronzo RA, et al: Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J Clin Invest 1985;76: 149.

    Article  PubMed  CAS  Google Scholar 

  9. Reaven GM: Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition. Annual Review of Medicine 1993;44: 121.

    Article  PubMed  CAS  Google Scholar 

  10. Ferrannini E, et al: Insulin resistance in essential hypertension. N Engl J Med 1987;317: 350.

    Article  PubMed  CAS  Google Scholar 

  11. Modan M, et al: Hyperinsulinemia, sex and risk of atherosclerotic cardiovascular disease. Circulation 1991;84: 1165.

    Article  PubMed  CAS  Google Scholar 

  12. Haffner SM, et al: Prospective analysis of insulin-resistance syndrome (symdrome X). Diabetes 1992;41: 715.

    Article  PubMed  CAS  Google Scholar 

  13. Blaustein MP: Sodium ions, calcium ions, blood pressure regulation, hypertension: reassessment and a hypothesis. Am J Physiol 1977;232: C165.

    PubMed  CAS  Google Scholar 

  14. Alzaid A, Rizza RA: Insulin resistance and its role in the patogenesis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus: perspectives gained from in vivo studies, in Moller DE (ed): Insulin Resistance. New York, Wiley, 1993, pp 143.

    Google Scholar 

  15. Bonora E, et al: Normal inhibition by somatostatin of glucose-stimulated B-cell secretion in obese subjects. Hormonal and Metabolic Research 1990;22: 584.

    Article  CAS  Google Scholar 

  16. Nestler JE: Assessment of insulin resistance. Scientific American 1994;12: 58.

    Google Scholar 

  17. Bergman RN, et al: Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236: E667.

    PubMed  CAS  Google Scholar 

  18. Swan JW, Walton C, Godsland IF: Assessment of insulin sensitivity in man: a comparison of minimal model-and euglycaemic clamp-derived measures in health and heart failure. Clin Sci 1994;86: 317.

    PubMed  CAS  Google Scholar 

  19. Saad MF, et al: A Comparison Between the Minimal Model and the Glucose Clamp in the Assessment of Insulin Sensitivity Across the Spectrum of Glucose Tolerance. Diabetes 1994;43: 1114.

    Article  PubMed  CAS  Google Scholar 

  20. Bergman RN, et al: Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79: 790.

    Article  PubMed  CAS  Google Scholar 

  21. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237: E214

    PubMed  CAS  Google Scholar 

  22. Sheu WHH, et al: Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension. Am J Hypertens 1991;4: 199.

    PubMed  CAS  Google Scholar 

  23. Eriksson J, et al: Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus. The New England Journal of Medicine 1989;321: 337.

    Article  PubMed  CAS  Google Scholar 

  24. Welborn TA, et al: Serum insulin in essential hypertension and in peripheral vascular disease. Lance 1966;1: 1336.

    Article  CAS  Google Scholar 

  25. Swislocki A, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance and hyperin-sulinemia in patients with hypertension. Am J Hypertens 1989;2: 419.

    PubMed  CAS  Google Scholar 

  26. Sechi LA, et al: Insulin resistance and beta-cell hypersecretion in essential hypertension. J Hypertens 1990;8: S87

    CAS  Google Scholar 

  27. Lind L, Lithell H, Pollare T: Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors. J Hypertens 1993; 11 Suppl. 4: S11

    Article  CAS  Google Scholar 

  28. Salomaa VV, et al: Glucose tolerance and blood pressure: long-term follow-up in middle-aged men. BMJ 1991;302: 493

    Article  PubMed  CAS  Google Scholar 

  29. Resnick LM: Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders: The mechanism of “syndrome X”. Am J Hypertens 1993;6: 123S

    PubMed  CAS  Google Scholar 

  30. Draznin B: Cytosolic calcium: a new factor in insulin resistance? Diabetes Research in Clinical Practice 1991;11: 141.

    Article  CAS  Google Scholar 

  31. Hellman B, Sehlin J, Taljedal JB: Calcium and secretion: distinction between two pools of glucose-sensitive calcium in pancreatic islets. Science 1976; 194: 1421.

    Article  PubMed  CAS  Google Scholar 

  32. Altura B, Carella A: Mg++-Ca+ + interaction in contractility of vascular smooth muscle: Mg+ + versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels. Canadian Journal of Physiologic Pharmacology 1987;65: 729.

    Article  CAS  Google Scholar 

  33. Skott P, et al: Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989;32: 694.

    Article  PubMed  CAS  Google Scholar 

  34. DeFronzo RA, et al: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55: 845.

    Article  PubMed  CAS  Google Scholar 

  35. Landsberg L, et al: Obesity, blood pressure, and the sympathetic nervous system. Annals of Epidemiology 1990; 1: 295.

    Article  Google Scholar 

  36. Abouchacra S, et al: Insulin Blunts the Natriuretic Action of Atrial Natriuretic Peptide in Hypertension. Hyper 1994;23: 1054

    Article  CAS  Google Scholar 

  37. Trevisan R, et al: Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 1990;39: 289.

    Article  PubMed  CAS  Google Scholar 

  38. Phillips RA, et al: Hemodynamic and humoral correlates of insulin resistance in non-obese borderline hypertensives-A preliminary report Blood Pressure 1996; 1: 72.

    CAS  Google Scholar 

  39. Scherrer U, et al: Nitric oxide release accounts for insulin’s vascular effects in humans. J Clin Invest 1994;94: 2511

    Article  PubMed  CAS  Google Scholar 

  40. Laasko M, et al: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990;85: 1844

    Article  Google Scholar 

  41. Laakso M, et al: Impaired insulin-mediated skeletal muscle blood flow in patients with NID-DM. Diabetes 1992;41: 1076

    Article  PubMed  CAS  Google Scholar 

  42. Baron AD, et al: Skeletal muscle blood flow: A possible link between insulin resistance and blood pressure. Hypertension 1993;21: 129

    Article  PubMed  CAS  Google Scholar 

  43. Feldman RD, Bierbrier GS: Insulin-mediated vasodilation: Impairment with increased blood pressure and body mass. Lancet 1993;342: 707

    Article  PubMed  CAS  Google Scholar 

  44. Baron AD, et al: Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men. J Clin Invest 1994;93: 2453

    Article  PubMed  CAS  Google Scholar 

  45. Forte P, et al: Basal nitric oxide synthesis in essential hypertension [see comments]. Lancet 1997;349: 837

    Article  PubMed  CAS  Google Scholar 

  46. Petrie JR, et al: Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996;93: 1331

    Article  PubMed  CAS  Google Scholar 

  47. Jansson PA, et al: Measurement by microdialysis of the insulin concentration in subcutaneous interstitial fluid. Importance of the endothelial barrier for insulin. Diabetes 1993;42: 1469

    Article  PubMed  CAS  Google Scholar 

  48. Bergman RN, et al: The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model. Horm Metab Res Suppl 1990;24: 49

    PubMed  CAS  Google Scholar 

  49. Julius S, et al: The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991;9: 983

    Article  PubMed  CAS  Google Scholar 

  50. Pinkney JH, et al: Endothelial dysfunction: Cause of the insulin resistance syndrome. Diabetes 1997;46: S9

    PubMed  CAS  Google Scholar 

  51. Jamerson KA, et al: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993;21: 618

    Article  PubMed  CAS  Google Scholar 

  52. J-amerson KA, et al: Vasoconstriction With Norepinephrine Causes Less Forearm Insulin Resistance Than a Reflex Sympathetic Vasoconstriction. Hyper 1994;23: 1006

    Article  CAS  Google Scholar 

  53. Rowe JW, et al: Effects of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30: 219

    PubMed  CAS  Google Scholar 

  54. Anderson EA, et al: Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992; 19: 621

    Article  PubMed  CAS  Google Scholar 

  55. Supiano MA, et al: Hypertension and insulin resistance: role of sympathetic nervous system activity. Am J Physiol 1992;263: E935

    PubMed  CAS  Google Scholar 

  56. Zavaroni I, et al: Risk factors for coronary artery disease in healthy persons with hyperin-sulinemia and normal glucose tolerance. N Engl J Med 1989;320: 702

    Article  PubMed  CAS  Google Scholar 

  57. Hollenbeck CB, et al: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984;33: 460

    Article  PubMed  CAS  Google Scholar 

  58. Ferrannini E: Syndrome X. Hormone Research 1993;39: 107

    Google Scholar 

  59. Burke GL, et al: Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: the Bogalusa Heart Study. Metabolism 1986;35: 441

    Article  PubMed  CAS  Google Scholar 

  60. Manolio TA, et al: Association of Fasting Insulin with Blood Pressure and Lipids in Young Adults-The CARDIA Study. Arteriosclerosis 1990;10: 430

    Article  PubMed  CAS  Google Scholar 

  61. Pyorala K, et al: Plasma Insulin as Coronary Heart Disease Risk Factor: Relationship to other Risk Factors and Predictive Value during 91/2-year Follow-up of the Helsinki Policemen Study Population. Acta Med Scand 1985;701: 38

    CAS  Google Scholar 

  62. Fontbonne AM, et al: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: The Paris prospective study, 15 year follow-up. Diabetologia 1991;34: 356.

    Article  PubMed  CAS  Google Scholar 

  63. Welborn TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2: 154

    Article  PubMed  CAS  Google Scholar 

  64. Cruz AB, et al: Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circulatory Research 1961;9: 39.

    Article  CAS  Google Scholar 

  65. Bierman EL: Atherogenesis in Diabetes. George Lyman Duff Memorial Lecture. Aterior-scler-Thromb 1992; 12: 647.

    Article  CAS  Google Scholar 

  66. Oppenheimer MJ, Sundquist K, Bierman EL: Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I. Diabetes 1989;38: 117

    Article  PubMed  CAS  Google Scholar 

  67. Hu R-M, et al: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993;42: 351

    Article  PubMed  CAS  Google Scholar 

  68. Kurtz TW, Hamoudi AA, Morris RCJ: “Salt sensitive” essential hypertension in men: Is the sodium ion alone important? N Engl J Med 1987;317: 1043

    Article  PubMed  CAS  Google Scholar 

  69. Dean JD, et al: Hyperinsulinemia and microvascular angina (“syndrome X”). Lancet 1991;337: 456

    Article  PubMed  CAS  Google Scholar 

  70. Botker HE, et al: Insulin resitance in microvascular angina (syndrome X). Lancet 1993;342: 136

    Article  PubMed  CAS  Google Scholar 

  71. Schunkert H, et al: Localization and regulation of c-fos and c-jun protooncogene induction by systolic wall stress in normal and hypertrophied rat hearts. Proc Natl Acad Sci USA 1991;88: 11480

    Article  PubMed  CAS  Google Scholar 

  72. Ganau A, et al: Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990;81: 25

    Article  PubMed  CAS  Google Scholar 

  73. Frohlich ED, Tarazi RC: Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 1979;44: 959

    Article  PubMed  CAS  Google Scholar 

  74. Phillips RA, Krakoff LR, Ardeljan M, Dunaif A, Finegood DT, Shimabukuro S, Gorlin R, Wilkenfeld C: Relation of left ventricular mass to insulin resistance and blood pressure in non-obese subjects. J Am Coll Cardiol 1994;23: 48A(Abstract)

    Google Scholar 

  75. Lopes De Faria JB, et al: Sodium-lithium countertransport activity and insulin resistance in normotensive IDDM patients. Diabetes 1992;41: 610

    Article  Google Scholar 

  76. Grossman E, et al: Left ventricular mass in diabetes-hypertension. Arch Intern Med 1992;152: 1001

    Article  PubMed  CAS  Google Scholar 

  77. Sharp SD, Williams RR: Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology 1992;81: 207

    Article  PubMed  CAS  Google Scholar 

  78. Sasson Z, et al: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88: 1431

    Article  PubMed  CAS  Google Scholar 

  79. Marcus R, et al: Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study. Circulation 1994;90: 928

    Article  PubMed  CAS  Google Scholar 

  80. Lind L, et al: Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433

    PubMed  CAS  Google Scholar 

  81. Stein IF, Leventhal ML: Amenorrhea associated with bilateral polycystic ovaries. Am J Ob-stet Gynecol 1935;29: 181

    Google Scholar 

  82. Dunaif A, et al: Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 1989;38: 1165

    Article  PubMed  CAS  Google Scholar 

  83. Zimmerman S, et al: Polycystic ovary syndrome: Lack of hypertension despite profound insulin resistance. J Clin Endocrin Metab 1992;75: 508

    Article  Google Scholar 

  84. Birkeland KI, et al: Relationship Between Blood Pressure and In Vivo Action of Insulin in Type II (Non-Insulin-Dependent) Diabetic Subjects. Metabolism 1992;41: 301

    Article  PubMed  CAS  Google Scholar 

  85. Ferrannini E, Haffner SM, Stern MP: Essential Hypertension: An Insulin-Resistant State. J Cardiovasc Pharmacol 1990;15: S18

    PubMed  CAS  Google Scholar 

  86. Zavaroni I, et al: Hyperinsulinaemia, obesity, and syndrome X. J Int Med 1994;235: 51

    Article  CAS  Google Scholar 

  87. Evans DJ, et al: Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic abnormalities in pre-menopausal women. J Clin Endocrinol Metab 1983;57: 304

    Article  PubMed  CAS  Google Scholar 

  88. Haffner SM, Dunn JF, Katz MS: Relationship of sex hormone binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in post-menopausal women. Atherosclerosis 1992;41: 278

    CAS  Google Scholar 

  89. Haffner SM, et al: Decreased Sex Hormone-Binding Globulin Predicts Noninsulin-Depen-dent Diabetes Mellitus in Women but not in Men. J Clin Endocrinol Metab 1993;77: 56

    Article  PubMed  CAS  Google Scholar 

  90. Lindstedt G, et al: Low sex hormone binding globulin concentration as independent risk factor for development of NIDDM: 12-year follow-up of population study of women in Gothenburg, Sweden. Diabetes 1990;40: 123

    Article  Google Scholar 

  91. Haffner SM, et al: Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 1994;43: 212

    Article  PubMed  CAS  Google Scholar 

  92. Anonymous: The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153: 154

    Google Scholar 

  93. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202: 1028

    Article  Google Scholar 

  94. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension II. results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213: 1143

    Article  Google Scholar 

  95. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242: 2562

    Article  Google Scholar 

  96. Multiple Risk Factor Intervention Trial Research Group: Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 1982;248: 1465

    Article  Google Scholar 

  97. Helgeland A: The treatment of mild hypertension: a five-year controlled drug trial; the Oslo study. Am J Med 1980;69: 725

    Article  PubMed  CAS  Google Scholar 

  98. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Brit Med J 1985;291: 97

    Article  Google Scholar 

  99. Collins R, et al: Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335: 827

    Article  PubMed  CAS  Google Scholar 

  100. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorthiazide and capto-pril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989;321: 868

    Article  PubMed  CAS  Google Scholar 

  101. Ferrari P, Rosman J, Wiedmann P: Antihypertensive agents, serum lipoproteins, and glucose metabolism. Am J Cardiol 1991;67: 26B

    Article  PubMed  CAS  Google Scholar 

  102. Wiedmann P, et al: Antihypertensive therapy in diabetic patients. J Hum Hypertens 1993;7

    Google Scholar 

  103. Lind L, et al: Long-term metabolic effects of antihypertensive drugs. Am Heart J 1994; 128: 1177

    Article  PubMed  CAS  Google Scholar 

  104. Lithell HOL: Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991;14: 203

    Article  Google Scholar 

  105. Warram JH, et al: Excess mortality associated with diuretic therapy in diabets mellitus. Arch Intern Med 1991;151: 1350

    Article  PubMed  CAS  Google Scholar 

  106. Curb JD, et al: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276: 1886

    Article  PubMed  CAS  Google Scholar 

  107. Skarfors ET, et al: Do antihypertensive drugs precipitate diabetes in predisposed men? Brit Med J 1989;298: 1147

    Article  PubMed  CAS  Google Scholar 

  108. Bengtsson C, et al: Do antihypertensive drugs precipitate diabetes? Brit Med J 1984;289: 1495

    Article  CAS  Google Scholar 

  109. Kendall MJ, et al: Beta blockers and sudden cardiac death. Ann Intern Med 1995;123: 358

    PubMed  CAS  Google Scholar 

  110. Moan A, et al: Hypertension therapy and risk of coronary heart disease: How do antihypertensives affect metabolic factors? Cardiology 1995;86: 89

    Article  PubMed  CAS  Google Scholar 

  111. Helgeland A, et al: Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway. Lance 1986;328: 872

    Article  Google Scholar 

  112. Alkharouf J, et al: Long-term effects of the angiotensin converting enzyme inhibitor capto-pril on metabolic control in non-insulin-dependent diabetes mellitus. Am J Hypertens 1993;6: 337

    PubMed  CAS  Google Scholar 

  113. Jauch KW, et al: Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Europ J Clin Invest 1987; 17: 448

    Article  PubMed  CAS  Google Scholar 

  114. Torlone E, et al: ACE inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991;34: 119

    Article  PubMed  CAS  Google Scholar 

  115. Bak JF, et al: Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients. Am J Med 1992;92: 69S

    Article  PubMed  CAS  Google Scholar 

  116. Mattews DM, Wathen CG, Bell D: The effect of captopril on blood pressure and glucose tolerance in hypertensive non-insulin-dependent diabetes. Postgrad Med J 1986;62: 73

    Google Scholar 

  117. Dominguez JR, et al: Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus. Postgrad Med J 1986;62: 66

    PubMed  Google Scholar 

  118. Lithell HO, Pollare T, Berne C: Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters. J Cardiovasc Pharm 1990;15: S46

    Google Scholar 

  119. Paolisso G, et al: ACE inhibition improves insulin sensitivity in aged insulin-resistant hypertensive patients. J Hum Hyperten 1992;6: 175

    CAS  Google Scholar 

  120. Kodama J, et al: Effect of captopril on glucose concentration: possible role of augmented postprandial forearm blood flow. Diabetes Care 1990; 13: 1109

    Article  PubMed  CAS  Google Scholar 

  121. Santoro D, et al: Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension 1992;20: 181

    Article  PubMed  CAS  Google Scholar 

  122. Tomiyama H, et al: Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitors. Hypertension 1994;23: 450

    Article  PubMed  CAS  Google Scholar 

  123. Baba T, Kodama T, Ishizaki T: Effect of chronic treatment with enalapril on glucose tolerance and serum insulin responsen to glucose load in non-insulin-resistant Japanese patients with essential hypertension. Euro J Clin Pharm 1993;45: 23

    Article  CAS  Google Scholar 

  124. Allemann Y, et al: Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril. Euro J Clin Pharm 1992;42: 275

    CAS  Google Scholar 

  125. Gans ROB, et al: The effect of angiotensin-1 converting enzyme inhibition on insulin action in healthy volunteers. Europ J Clin Invest 1991;21: 527

    Article  PubMed  CAS  Google Scholar 

  126. Maheux P, et al: Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Am J Hypertens 1994;7: 416

    PubMed  CAS  Google Scholar 

  127. Erman A, et al: Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats. J Pharmacol Exp Ther 1986;239: 296

    PubMed  CAS  Google Scholar 

  128. Swislocki ALM, et al: Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension. Am J Med 1989;13: 14

    Article  Google Scholar 

  129. Giorda C, Appendino M: Effects of doxazosin, a selective a,-inhibitor, on plasma insulin and blood glucose response to a glucose tolerance test in essential hypertension. Metabolism 1993;42: 1440

    Article  PubMed  CAS  Google Scholar 

  130. Wilson MD, Weart CW: Hypertension: Are beta-blockers and diuretics appropriate first-line therapies? Ann Pharmacol 1994;28: 617

    CAS  Google Scholar 

  131. Caldwell BV: Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers. Clinical Therapeutics 1993; 15: 618

    PubMed  CAS  Google Scholar 

  132. Pollare T, et al: Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989;7: 551

    Article  PubMed  CAS  Google Scholar 

  133. Morris AD, et al: Metabolic effects of lacidipine: a placebo-controlled study using the eug-lycaemic, hyperinsulinaemic clamp. Brit J Clin Pharm 1993;35: 40

    PubMed  CAS  Google Scholar 

  134. Collins WCJ, Cullen MJ, Feely J: Calcium channel blocker drugs and diabetic control. Clin Pharm Therapeut 1987;42: 420

    Article  CAS  Google Scholar 

  135. Faguer de Moustier B, Paoli V: The influence of nicardipine in type II diabetic patients with slight hypertension. J Cardiovasc Pharm 1990;16: S26

    Google Scholar 

  136. Hedner T, et al: Glucose tolerance in hypertensive patients during treatment with the calcium antagonist felodipine. Brit J Clin Pharm 1987;24: 145

    Article  PubMed  CAS  Google Scholar 

  137. Kihara A: Effect of the calcium antagonist nicardipine hydrochloride on glucose tolerance and insulin secretion. Am Heart J 1991;122: 363

    Article  PubMed  CAS  Google Scholar 

  138. Trost BN, Wiedmann P: Effect of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review. J Hypertens 1987;5: 81

    Article  Google Scholar 

  139. Sasaki J, et al: Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension. Am J Hypertens 1994;7: 161S

    PubMed  CAS  Google Scholar 

  140. Griffing GT, et al: Plasma beta-endorphin levels in primary aldosteronsim. J Clin Endocrinol Metab 1985;60: 315

    Article  PubMed  CAS  Google Scholar 

  141. Iwamoto Y, Kuzuya T, Matsuda A: Effects of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 1991;14: 1083

    Article  PubMed  CAS  Google Scholar 

  142. Fujiwara T, et al: Characterization of new oral antidiabetic agent CS-045: studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988;37: 1549

    Article  PubMed  CAS  Google Scholar 

  143. Ciaraldi TP, et al: In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism 1990;39: 1056

    Article  PubMed  CAS  Google Scholar 

  144. Phillips RA: The cardiologist’s approach to evaluation and management of the patient with essential hypertension. Am Heart J 1993; 126: 648

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Frederick B. Slogoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric J. Wasserman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert A. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Slogoff, F.B., Wasserman, E.J., Phillips, R.A. (1999). Insulin Resistance, and Hypertension. In: Contemporary Concepts in Cardiology. Developments in Cardiovascular Medicine, vol 217. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5007-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5007-5_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7274-5

  • Online ISBN: 978-1-4615-5007-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation